SCHEMBL2599191

SCHEMBL2599191

O=C1NCC2CNCC2c2cc(F)ccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 5/20 0.42
CHRNB2 P17787 1/20 0.41
CHRNB4 P30926 1/20 0.41
CHRNA3 P32297 1/20 0.41
CHRNA4 P43681 1/20 0.41
PARP10 Q53GL7 2/20 0.39
PARP1 P09874 1/20 0.39
HTR2A P28223 3/20 0.37
HTR2B P41595 2/20 0.37
FABP6 P51161 1/20 0.36
GRM5 P41594 3/20 0.35
PARP3 Q9Y6F1 1/20 0.35
MKNK1 Q9BUB5 1/20 0.33
PARP11 Q9NR21 1/20 0.33
JAK2 O60674 2/20 0.33
ALK Q9UM73 2/20 0.33
SLC34A2 O95436 1/20 0.33
CD74 P04233 1/20 0.33
NTRK1 P04629 1/20 0.33
ROS1 P08922 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL860215 1.00 HTR2C (0.42) HTR2CCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL860214 1.00 HTR2C (0.42) HTR2CCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL2599193 1.00 HTR2C (0.42) HTR2CCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL2599007 0.88 HTR2C (0.42) HTR2CCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL2599004 0.88 HTR2C (0.42) HTR2CCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL1805752 0.88 HTR2C (0.42) HTR2CCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL1805749 0.88 HTR2C (0.42) HTR2CCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL1805624 0.82 HTR2C (0.50) HTR2CCHRNB2CHRNA4PARP10PARP1
SCHEMBL1805626 0.82 HTR2C (0.50) HTR2CCHRNB2CHRNA4PARP10PARP1
SCHEMBL861164 0.81 HDAC2 (0.37) HTR2CCHRNB2CHRNB4CHRNA3CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2571353-A1 MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF AbbVie Inc. (US) 2013-03-27 EP disclosed
WO-2011146089-A1 MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF ABBOTT LABORATORIES (US) 2011-11-24 WO disclosed